6-130144542-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001017373.4(SAMD3):c.1541G>A(p.Gly514Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,613,842 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001017373.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAMD3 | NM_001017373.4 | c.1541G>A | p.Gly514Glu | missense_variant | 12/12 | ENST00000439090.7 | NP_001017373.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAMD3 | ENST00000439090.7 | c.1541G>A | p.Gly514Glu | missense_variant | 12/12 | 2 | NM_001017373.4 | ENSP00000403565.2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000128 AC: 32AN: 250822Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135554
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461646Hom.: 1 Cov.: 31 AF XY: 0.0000674 AC XY: 49AN XY: 727126
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.1541G>A (p.G514E) alteration is located in exon 12 (coding exon 10) of the SAMD3 gene. This alteration results from a G to A substitution at nucleotide position 1541, causing the glycine (G) at amino acid position 514 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at